Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 16, 2021, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited receives USFDA Final Approval for Testosterone Topical Solution USP, 30 mg per pump actuation".